Review began 04/04/2023 review ended 04/13/2023 published 04/16/2023 © copyright

HIGHLIGHTS

• who: Report and collaborators from the (UNIVERSITY) have published the article: Review began 04/04/2023 Review ended 04/13/2023 Published 04/16/2023 u00a9 Copyright, in the Journal: (JOURNAL) of April/16,/2023
• what: The management of HI in pediatric patients remains a significant challenge due to its rarity and the absence of FDA-approved treatments.
• future: This case highlights that although ustekinumab may be a viable treatment option for other ichthyotic entities more research is needed to evaluate its clinical safety and efficacy in treating pediatric patients with HI.
 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.